Cardiovascular manifestations of sickle cell disease
- 1 April 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (13), 1365-1373
- https://doi.org/10.1093/eurheartj/ehz217
Abstract
Sickle cell disease (SCD) is the most frequent genetic haemoglobinopathy worldwide. Early childhood mortality has dramatically decreased in high-income countries, and most patients now survive beyond the 5th decade. However, in the aging SCD population, the morbidity related to chronic organ damage, especially kidney and heart, has become a major concern. While pulmonary hypertension has attracted most attention, it appears that this condition is frequently linked to left heart failure (HF). Accordingly, SCD-associated cardiomyopathy is emerging as a major cause of reduced quality of life and early mortality in these patients. The diagnosis of this particular phenotype of high-output HF is challenging. Exercise intolerance and dyspnoea in SCD patients are linked to multiple causes including chronic anaemia. Moreover, echocardiographic features are unusual and can be misinterpreted. The classical diagnosis algorithm for HF is generally not suitable in SCD patients, and HF is poorly recognized and mostly diagnosed at a late congestive stage in routine practice. Such patients need to be identified at an earlier stage of myocardial dysfunction via improved phenotyping. This constitutes the first step towards further investigations in SCD needed to improve the prognosis and the quality of life. This article provides an updated review of the recent advances in the pathophysiology and diagnosis, and in addition, perspectives of new therapeutic approaches in SCD-related cardiac manifestations.Funding Information
- AstraZeneca
- Beth Israel Deaconess Medical
- Brigham Women’s Hospital
- Cardiovascular Research Foundation
This publication has 76 references indexed in Scilit:
- Pulmonary Artery Occlusion Pressure May Overdiagnose Pulmonary Artery Hypertension in Sickle Cell DiseaseClinical Cardiology, 2013
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimatesThe Lancet, 2013
- Hemodynamic Characteristics and Predictors of Pulmonary Hypertension in Patients With Sickle Cell DiseaseThe American Journal of Cardiology, 2012
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Hemoglobin sickle cell disease complications: a clinical study of 179 casesHaematologica, 2012
- Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United KingdomJournal of the American College of Cardiology, 2011
- Evaluation of 107 Patients With Sickle Cell Anemia Through Tissue Doppler and Myocardial Performance IndexJournal of the American Society of Echocardiography, 2008
- Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell DiseaseJournal of Invasive Cardiology, 2007
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseThe New England Journal of Medicine, 2004
- Cardiovascular effects of anemiaAmerican Heart Journal, 1972